Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-07-04
2006-07-04
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C435S334000, C564S049000
Reexamination Certificate
active
07071231
ABSTRACT:
Compounds of formula I are useful for treating conditions associated with hyperglycemia, especially Type II diabetes. These compounds are useful in stimulating the kinase activity of the insulin receptor, activating the insulin receptor, and stimulating the uptake of glucose. Pharmaceutical compositions comprising the antidiabetic compounds are also disclosed.
REFERENCES:
patent: 3716368 (1973-02-01), Froehlich et al.
patent: 4051176 (1977-09-01), Bernstein et al.
patent: 4102917 (1978-07-01), Conrow et al.
patent: 4118232 (1978-10-01), Piller et al.
patent: 4120891 (1978-10-01), Poletto et al.
patent: 4129591 (1978-12-01), Bernstein et al.
patent: 4132730 (1979-01-01), Conrow et al.
patent: 4591604 (1986-05-01), Conrow et al.
patent: 5830918 (1998-11-01), Sportsman et al.
patent: 22 16 592 (1972-10-01), None
patent: 195 21 589 (1996-12-01), None
patent: 1.578.556 (1969-08-01), None
patent: 58-191772 (1983-11-01), None
patent: WO 98/32017 (1988-07-01), None
patent: WO 98/32017 (1998-07-01), None
patent: WO 98/50347 (1998-11-01), None
patent: WO 98/50347 (1998-11-01), None
Suramin Sodium.The Merck Index, 10 ed., Merck & Co., Inc., Rahway NJ, 1983, entry 8890, p. 1294.
STN, Caplus Accession No. 1988:436172, 1988; and Ya. Ya. Aleksandrovskii, “The role of complement system activation inhibitors in the pathogenesis and therapy of insulin-dependent diabetes mellitus”,Vopr. Med. Chim., 34(3), 7-15 (1988) [article in Russian].
Kozlowski Michael R.
Lum Robert T.
Manchem Prasad V. V. S. V.
Schow Steven R.
Shi Songyuan
Hanley Susan
Telik, Inc.
Witz Jean C.
LandOfFree
Naphthalene ureas as glucose uptake enhancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthalene ureas as glucose uptake enhancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalene ureas as glucose uptake enhancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3574577